Metformin increases 18F-FDG flux and inhibits fatty acid oxidation at clinical doses in breast cancer: Results of a phase 0 clinical trial. Issue 11 (November 2016) - Lord, Simon; Liu, Dan; Cheng, Wei-Chen; Haider, Syed; Gaude, Edoardo; Teoh, Eugene; Patel, Neel; Metcalf, Tom; McGowan, Daniel; Roxanis, Ioannis; Qifeng, Zhang; Roy, Pankaj; et al.